AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.990
-0.120 (-3.86%)
Sep 6, 2024, 4:00 PM EDT - Market closed

AC Immune Revenue

AC Immune had revenue of 687.00K CHF in the quarter ending June 30, 2024. This brings the company's revenue in the last twelve months to 15.49M, up 293.60% year-over-year. In the year 2023, AC Immune had annual revenue of 14.80M with 276.14% growth.

Revenue (ttm)
15.49M CHF
Revenue Growth
+293.60%
P/S Ratio
16.06
Revenue / Employee
96,199 CHF
Employees
161
Market Cap
295.83M USD

Revenue Chart

* This company reports financials in CHF.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202314.80M10.87M276.14%
Dec 31, 20223.94M--
Dec 31, 2021---
Dec 31, 202015.43M-95.03M-86.03%
Dec 31, 2019110.46M103.54M1,498.03%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Aurora Cannabis 203.84M
Vanda Pharmaceuticals 182.02M
Talkspace 172.54M
Spok Holdings 138.27M
Alimera Sciences 99.68M
Editas Medicine 67.03M
TScan Therapeutics 12.20M
MeiraGTx Holdings 8.12M
Revenue Rankings